Platinum Twin and Triplet Drugs Improve Chemoimmunotherapy by Yuhao Hao (16938532)

“…The twin and triplet drugs exhibited significantly improved synergy with anti-PD-1 in a CT26 colorectal mouse tumor model. …”

Platinum Twin and Triplet Drugs Improve Chemoimmunotherapy by Yuhao Hao (16938532)

“…The twin and triplet drugs exhibited significantly improved synergy with anti-PD-1 in a CT26 colorectal mouse tumor model. …”

Predictors of coronary hyperemic DPV decrease after percutaneous coronary intervention. by Eisuke Usui (12111855)

Subjects:

Number and percentage of AE patients with detectable Em2+ antibodies at different visits and significance level in binominal test. by Beate Grüner (301524)

Subjects:

Behaviors with a significant main effect or interaction. by Grace Hecker (18813445)

Subjects:

Forest plot of the improvement in primary endpoints. by Jin-Min Gu (17915039)

Subjects:

Radar graph of absolute correlations between age, disease duration and disease variables. by Sasivimol Virameteekul (11868977)

Subjects:

Three portions are defined by subdividing both the lesser and the greater curvatures into three equal lengths. by Masaaki Kodama (212905)

Statistically-significant cytokine changes between the pre-infusion and post-infusion blood draws plot of the mean (dot) and confidence interval (whiskers) for the coefficients of... by Jordan K. Abbott (8934239)

Subjects:

Unconfined Compressive Strength of Improved Red Clay. by Quan Shen (37564)

Subjects:

AdMSC-EVs enhanced colony formation and migration of LECs and decreased proliferation. by Xiaoqin Li (1399105)

LSV2 abundance is greater in weak colonies. by Cayley Faurot-Daniels (9354170)

Correlation of Module Membership (MM) with Gene Significance (GS) in the four most relevant modules for PD. by Guanghao Xin (17583227)

Between-group comparison of change in VAS score by disease duration. by Myung-Geun Song (2297794)

Subjects:

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”

Radar graph of odds ratio visualization for disease milestones difference by age and disease duration. by Sasivimol Virameteekul (11868977)

Subjects:

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.</p>…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.</p>…”